DC
KERX

Deere & Company’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Deere & Company’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,648
Closed -$174K – 1108
2014
Q3 		$174K Buy
+12,648
New +$194K 0.01% 921

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deere & Company's KERX Position: Q4 2014 in Review

Deere & Company sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2014, closing a stake of 12,648 shares — an estimated $174K sold.

Deere & Company first reported a position in KERX in Q3 2014 and held it in 1 quarter. The position peaked at $174K in Q3 2014. 147 funds tracked by Wall St. Rank hold KERX as of Q4 2014.

  • Deere & Company reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2014 after selling out during the quarter.
  • Deere & Company sold 12,648 Keryx Biopharmaceuticals Inc shares in Q4 2014, an estimated $174K.
  • Deere & Company first reported a position in Keryx Biopharmaceuticals Inc in Q3 2014 and held it in 1 quarter.
  • Deere & Company's Keryx Biopharmaceuticals Inc position peaked at $174K in Q3 2014.
  • 147 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2014.

Based on Deere & Company's 13F filing for Q4 2014, filed 12 Feb 2015.